Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;37(5):1519-1524.
doi: 10.1007/s13187-021-01992-6. Epub 2021 Mar 19.

HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors

Austin R Waters  1 , Karely Mann  2 , Perla L Vaca Lopez  2 , Deanna Kepka  2   3 , Yelena P Wu  2   4 , Anne C Kirchhoff  2   5
Affiliations

HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors

Austin R Waters et al. J Cancer Educ. 2022 Oct.

Abstract

Cancer survivors are at higher risk of developing HPV-associated cancers later in life, yet their HPV vaccination rates remain lower than the general population. Improving HPV vaccination uptake among survivors is essential to preventing second malignancies. We interviewed HPV vaccine eligible adolescent and young adult (AYA) cancer survivors (18-26 years) and caregivers of HPV vaccine eligible childhood cancer survivors approaching the AYA age range (9-17 years) about their HPV vaccine experiences and preferences as informed by the HPV Vaccination Roundtable Best Practices. Interviews (N = 20) were recorded, transcribed, and analyzed using interpretive description. Of AYA survivors (n = 10), 50% had received at least one HPV vaccine dose. Of caregivers (n = 10), 30% reported their child had received at least one HPV vaccine dose. Three distinct categories emerged including (1) HPV vaccine knowledge, (2) HPV vaccination recommendation preferences, and (3) HPV vaccination reminder preferences. The first two categories were oncology focused. Participants lacked knowledge regarding HPV vaccine safety and applicability due to their complex cancer history. Most participants strongly preferred that their oncologist provide an HPV vaccine recommendation. The third category was mixed, with some participants preferring oncology-based HPV vaccine reminders while others preferred primary care-based reminders. Almost all participants preferred digital reminders (e.g., text messages). Our results suggest that oncologists play an essential role in recommending the HPV vaccine and providing information to assist survivors and caregivers with vaccine decision-making. Additionally, HPV vaccination uptake among pediatric and childhood and AYA survivors could be improved through the use of tailored, electronically delivered vaccine reminders.

Keywords: Caregiver; HPV vaccine; Survivorship; Survivorship guidelines; Text messaging.

PubMed Disclaimer

References

    1. Bhatia S, Sklar C (2002) Second Cancers in Survivors of Childhood Cancer. Nature Reviews Cancer 2 (2):124–132. doi: 10.1038/nrc722 - DOI - PubMed
    1. Huang SF, Li HF, Liao CT, Wang HM, Chen IH, Chang J-C, Chen YJ, Cheng AJ (2012) Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Diseases 18 (8):809–815. doi: 10.1111/j.1601-0825.2012.01950.x - DOI - PubMed
    1. Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG (2013) Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One 8 (8):e70349. doi: 10.1371/journal.pone.0070349 - DOI - PMC - PubMed
    1. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H (2013) Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008. Sexually Transmitted Diseases 40 (3):187–193. doi: 10.1097/OLQ.0b013e318286bb53 - DOI - PubMed
    1. Joura EA, Pils S (2016) Vaccines against human papillomavirus infections: protection against cancer, genital warts or both? Clinical Microbiology and Infection 22:S125–S127. doi: 10.1016/j.cmi.2016.12.017 - DOI - PubMed

Publication types

Substances